Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis

Objective: For years, it has been acknowledged that cancer cells contribute to aberrant DNA methylation, an epigenetic alteration. DNA methyltransferase 1 (DNMT1) is a large multidomain protein critical DNMT in cells. Due to its significant function in epigenetic control, DNMT1 is a viable candidate...

Full description

Saved in:
Bibliographic Details
Main Authors: Asma Khorshid Shamshiri, Maryam Alidoust, Fahimeh Afzaljavan
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2024-12-01
Series:Cell Journal
Subjects:
Online Access:https://www.celljournal.org/article_723111_d41d8cd98f00b204e9800998ecf8427e.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850119576802557952
author Asma Khorshid Shamshiri
Maryam Alidoust
Fahimeh Afzaljavan
author_facet Asma Khorshid Shamshiri
Maryam Alidoust
Fahimeh Afzaljavan
author_sort Asma Khorshid Shamshiri
collection DOAJ
description Objective: For years, it has been acknowledged that cancer cells contribute to aberrant DNA methylation, an epigenetic alteration. DNA methyltransferase 1 (DNMT1) is a large multidomain protein critical DNMT in cells. Due to its significant function in epigenetic control, DNMT1 is a viable candidate gene for cancer susceptibility. The relationships between DNMT1 polymorphisms and cancer risk have been investigated; however, the outcomes are inconsistent. This metaanalysis aims to clarify the relationships between DNMT1 polymorphisms and cancer susceptibility.Materials and Methods: PubMed, Web of Science, and Scopus databases were systematically searched using specific search terms to identify potentially eligible papers published before January 2025. Fixed-effects or randomeffects models were employed to calculate odds ratios (OR) and 95% confidence intervals (CI). The I² statistic and Egger’s test were utilised to evaluate inter-study heterogeneity and assess the presence of publication bias among the included studies. All statistical analyses were conducted using MetaGenyo software.Results: A total of 776 articles were retrieved from PubMed, Scopus, and Web of Science databases. After full-text evaluation and applying the literature selection criteria, 23 articles were included as case-control studies that assessed the relationship between 23 polymorphisms in DNMT1 and cancer risk were included. The rs2228612, rs2228611, rs16999593, and rs10420321 single nucleotide polymorphisms (SNPs) were most frequently investigated. The rs2228612 co-dominant model [P=0.037, OR=0.89, 95% CI (0.80-0.99)] and rs2228611 dominant model [P<0.001, OR=1.32, 95% CI (1.14-0.53)] revealed a substantial association with cancer risk. Subgroup analysis showed an association between the rs2228612 co-dominant [P=0.022, OR=0.58, 95% CI (0.74-0.98)] and recessive [P=0.046, OR=1.15, 95% CI (1.00-1.32)] models with gastrointestinal cancer and the rs2228611 co-dominant model with breast cancer [P=0.024, OR=1.15, 95% CI (1.02-1.29)].Conclusion: Although the current study found a role for DNMT1 polymorphisms in cancer risk, further high-quality studies are needed to validate these findings.
format Article
id doaj-art-926b1322a0804e4a87c313c6395ea706
institution OA Journals
issn 2228-5806
2228-5814
language English
publishDate 2024-12-01
publisher Royan Institute (ACECR), Tehran
record_format Article
series Cell Journal
spelling doaj-art-926b1322a0804e4a87c313c6395ea7062025-08-20T02:35:36ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142024-12-01261266968110.22074/cellj.2025.2045804.1716723111Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysisAsma Khorshid Shamshiri0Maryam Alidoust1Fahimeh Afzaljavan2Department of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Medical Genetics and Molecular Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Obstetrics and Gynecology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranObjective: For years, it has been acknowledged that cancer cells contribute to aberrant DNA methylation, an epigenetic alteration. DNA methyltransferase 1 (DNMT1) is a large multidomain protein critical DNMT in cells. Due to its significant function in epigenetic control, DNMT1 is a viable candidate gene for cancer susceptibility. The relationships between DNMT1 polymorphisms and cancer risk have been investigated; however, the outcomes are inconsistent. This metaanalysis aims to clarify the relationships between DNMT1 polymorphisms and cancer susceptibility.Materials and Methods: PubMed, Web of Science, and Scopus databases were systematically searched using specific search terms to identify potentially eligible papers published before January 2025. Fixed-effects or randomeffects models were employed to calculate odds ratios (OR) and 95% confidence intervals (CI). The I² statistic and Egger’s test were utilised to evaluate inter-study heterogeneity and assess the presence of publication bias among the included studies. All statistical analyses were conducted using MetaGenyo software.Results: A total of 776 articles were retrieved from PubMed, Scopus, and Web of Science databases. After full-text evaluation and applying the literature selection criteria, 23 articles were included as case-control studies that assessed the relationship between 23 polymorphisms in DNMT1 and cancer risk were included. The rs2228612, rs2228611, rs16999593, and rs10420321 single nucleotide polymorphisms (SNPs) were most frequently investigated. The rs2228612 co-dominant model [P=0.037, OR=0.89, 95% CI (0.80-0.99)] and rs2228611 dominant model [P<0.001, OR=1.32, 95% CI (1.14-0.53)] revealed a substantial association with cancer risk. Subgroup analysis showed an association between the rs2228612 co-dominant [P=0.022, OR=0.58, 95% CI (0.74-0.98)] and recessive [P=0.046, OR=1.15, 95% CI (1.00-1.32)] models with gastrointestinal cancer and the rs2228611 co-dominant model with breast cancer [P=0.024, OR=1.15, 95% CI (1.02-1.29)].Conclusion: Although the current study found a role for DNMT1 polymorphisms in cancer risk, further high-quality studies are needed to validate these findings.https://www.celljournal.org/article_723111_d41d8cd98f00b204e9800998ecf8427e.pdfdna methyltransferase 1geneticmeta-analysisneoplasmspolymorphism
spellingShingle Asma Khorshid Shamshiri
Maryam Alidoust
Fahimeh Afzaljavan
Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
Cell Journal
dna methyltransferase 1
genetic
meta-analysis
neoplasms
polymorphism
title Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
title_full Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
title_fullStr Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
title_full_unstemmed Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
title_short Associations between DNMT1 Gene Polymorphisms and Cancer Susceptibility: A Systematic Review and Meta-analysis
title_sort associations between dnmt1 gene polymorphisms and cancer susceptibility a systematic review and meta analysis
topic dna methyltransferase 1
genetic
meta-analysis
neoplasms
polymorphism
url https://www.celljournal.org/article_723111_d41d8cd98f00b204e9800998ecf8427e.pdf
work_keys_str_mv AT asmakhorshidshamshiri associationsbetweendnmt1genepolymorphismsandcancersusceptibilityasystematicreviewandmetaanalysis
AT maryamalidoust associationsbetweendnmt1genepolymorphismsandcancersusceptibilityasystematicreviewandmetaanalysis
AT fahimehafzaljavan associationsbetweendnmt1genepolymorphismsandcancersusceptibilityasystematicreviewandmetaanalysis